Sarah Freeland is a Clinical Operations and Research Manager with extensive experience leading the strategic planning and execution of clinical research programs. She ensures studies are conducted in compliance with GCP, FDA regulations, ICH guidelines, and internal SOPs, while supporting operational efficiency and organizational objectives.
Sarah serves as the primary liaison among principal investigators, sponsors, CROs, and internal stakeholders, fostering strong collaboration and clear communication. Her expertise includes overseeing study start-up activities such as feasibility assessments, budgeting, contract negotiations, and site initiation, as well as supporting protocol development, regulatory submissions, informed consent reviews, and safety reporting.
With a proactive approach to risk management and quality oversight, Sarah monitors site performance, ensures data integrity, and implements quality control measures to support successful trial execution. She is also committed to staff training, participant recruitment, and community engagement, providing education on clinical trials and Alzheimer’s research while building strong relationships with investigators and clinical teams to ensure smooth and compliant study operations.